PD-L1 蛋白
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PD-L1 Protein (AA 19-239) (DYKDDDDK Tag) | 人 | 人细胞 |
|
|
|
| PD-L1 Protein (AA 19-239) (His tag) | 人 | 人细胞 |
|
|
|
| PD-L1 蛋白 | 小鼠 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 蛋白 | 人 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 Protein (AA 19-238, Extracellular Domain, N-Term) (Fc Tag) | 人 | HEK-293 Cells |
|
|
|
| PD-L1 Protein (AA 19-237, Extracellular Domain, N-Term) (Fc Tag) | 小鼠 | CHO Cells |
|
|
|
| PD-L1 Protein (AA 18-238) (His tag) | 大鼠 | Mammalian Cells |
|
|
|
| PD-L1 Protein (AA 19-239) (Fc Tag) | Cynomolgus | 人细胞 |
|
|
|
| PD-L1 Protein (AA 19-238) (Fc Tag) | 小鼠 | 人细胞 |
|
|
|
| PD-L1 Protein (AA 34-241) (His tag,GST tag) | 大鼠 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 Protein (AA 48-290) (His tag) | 小鼠 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 Protein (AA 34-241) (His tag) | 小鼠 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 Protein (AA 24-234) (His tag) | 人 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 Protein (AA 19-238) (TRX tag) | 人 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 Protein (AA 19-238) (SUMO Tag) | 人 | 大肠杆菌(E. Coli) |
|
|
|
| PD-L1 Protein (AA 1-239) (His tag) | 人 | HEK-293 Cells |
|
|
|
| PD-L1 Protein (AA 1-239) (His tag) | 人 | HEK-293 Cells |
|
|
|
| PD-L1 蛋白 | 人 | 小麦胚 |
|
|
|
| PD-L1 Protein (mFc Tag) | 人 | HEK-293 Cells |
|
|
|
| PD-L1 Protein (DYKDDDDK Tag) | 人 | HEK-293 Cells |
|
|
- 宿主
- 人
- 宿主
- 人细胞
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- 宿主
- 人
- 宿主
- 人细胞
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- >98 % (SDS-PAGE)
- 生物活性
- Active
- 宿主
- 小鼠
- 宿主
- CHO Cells
- 蛋白类型
- Recombinant
- 纯度
- >98 % (SDS-PAGE)
- 生物活性
- Active
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 宿主
- 大鼠
- 宿主
- Mammalian Cells
- 蛋白类型
- Recombinant
- 纯度
- Greater than 95 % as determined by SDS-PAGE.
- 宿主
- 小鼠
- 宿主
- 人细胞
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- WB (Western Blotting: 所列应用)
- SDS (SDS-PAGE: 所列应用)
- Imm (Immunogen: 所列应用)
- PC (Positive Control: 所列应用)
- 宿主
- 大鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 90 %
- WB (Western Blotting: 所列应用)
- SDS (SDS-PAGE: 所列应用)
- Imm (Immunogen: 所列应用)
- PC (Positive Control: 所列应用)
- 宿主
- 小鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 80 %
- WB (Western Blotting: 所列应用)
- SDS (SDS-PAGE: 所列应用)
- Imm (Immunogen: 所列应用)
- PC (Positive Control: 所列应用)
- 宿主
- 小鼠
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 %
- WB (Western Blotting: 所列应用)
- SDS (SDS-PAGE: 所列应用)
- Imm (Immunogen: 所列应用)
- PC (Positive Control: 所列应用)
- 宿主
- 人
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 %
- Imm (Immunogen: 所列应用)
- 宿主
- 人
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 人
- 宿主
- 大肠杆菌(E. Coli)
- 蛋白类型
- Recombinant
- 纯度
- > 85 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- Imm (Immunogen: 所列应用)
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 90 % as determined by reducing SDS-PAGE.
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- ELISA (ELISA: 所列应用)
- BLI (Bio-Layer Interferometry: 所列应用)
- 宿主
- 人
- 宿主
- HEK-293 Cells
- 蛋白类型
- Recombinant
- 纯度
- > 95 % as determined by reducing SDS-PAGE.
- 生物活性
- Active
Latest Publications for our PD-L1 蛋白
: "PD-L1 aptamer isolation via Modular-SELEX and its applications in cancer cell detection and tumor tissue section imaging." in: The Analyst, Vol. 146, Issue 9, pp. 2910-2918, (2021) (PubMed).
: "Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors." in: EMBO molecular medicine, Vol. 12, Issue 6, pp. e11571, (2020) (PubMed).
: "Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models." in: Cancer research, Vol. 80, Issue 3, pp. 549-560, (2020) (PubMed).
: "Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. ..." in: Nature medicine, Vol. 26, Issue 5, pp. 732-740, (2020) (PubMed).
: "Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity." in: Cancer immunology, immunotherapy : CII, (2020) (PubMed).
: "In Vitro Assays to Study PD-1 Biology in Human T Cells." in: Current protocols in immunology, Vol. 130, Issue 1, pp. e103, (2020) (PubMed).
: "Comprehensive in vitro characterization of PD-L1 small molecule inhibitors. ..." in: Scientific reports, Vol. 9, Issue 1, pp. 12392, (2019) (PubMed).
: "Enhanced Expression of PD-L1 on Microglia After Surgical Brain Injury Exerts Self-Protection from Inflammation and Promotes Neurological Repair." in: Neurochemical research, Vol. 44, Issue 11, pp. 2470-2481, (2019) (PubMed).
: "A small-sized protein binder specific for human PD-1 effectively suppresses the tumour growth in tumour mouse model." in: Journal of drug targeting, pp. 1-9, (2019) (PubMed).
Aliases for PD-L1 蛋白
CD274 molecule (CD274) 蛋白CD274 antigen (Cd274) 蛋白
programmed cell death 1 ligand 2 (PDCD1LG2) 蛋白
CD274 molecule (Cd274) 蛋白
A530045L16Rik 蛋白
B7-H 蛋白
B7H1 蛋白
B7h1 蛋白
PD-L1 蛋白
PDCD1L1 蛋白
Pdcd1l1 蛋白
PDCD1LG1 蛋白
Pdcd1lg1 蛋白
PDL1 蛋白
Pdl1 蛋白
RGD1566211 蛋白